1 duplicate copy in the archive
EFTA Document EFTA01385523
Title Matchefta-efta01385523
Case Filesd-10-EFTA01385523Dept. of JusticeEFTA Document EFTA01385523
Unknown1p
Case File
sd-10-EFTA01385523Dept. of JusticeEFTA Document EFTA01385523
Other
> Energy, Materials & Industrials DSM - Virginie Boucher-Ferte, BUY, close €81.8, €100 tgt, 22% potential upside • We see Nutrition (68% of EBITDA) as a key growth driver. We forecast a 9% EBITDA 2018-20E CAGR driven by cost cutting, innovation and leverage of its broad portfolio. - A greater proportion of the Nutrition portfolio is in higher-value and faster-growing ingredients and 'solutions' rather than just vitamins. • Up to 30% upside to 18E EBITDA forecast if vitamin price increases
Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01385523
Pages
1
Persons
0
Integrity
Loading document viewer...
Forum Discussions
Advertisement
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.